IT1237482B - Alkanoid derived from L-Norcarnitina, preparation process and pharmaceutical composition.
- Google Patents
Alkanoid derived from L-Norcarnitina, preparation process and pharmaceutical composition.
Info
Publication number
IT1237482B
IT1237482BIT04869289AIT4869289AIT1237482BIT 1237482 BIT1237482 BIT 1237482BIT 04869289 AIT04869289 AIT 04869289AIT 4869289 AIT4869289 AIT 4869289AIT 1237482 BIT1237482 BIT 1237482B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind FarmaceutifiledCriticalSigma Tau Ind Farmaceuti
Priority to IT04869289ApriorityCriticalpatent/IT1237482B/en
Publication of IT8948692A0publicationCriticalpatent/IT8948692A0/en
Publication of IT8948692A1publicationCriticalpatent/IT8948692A1/en
Application grantedgrantedCritical
Publication of IT1237482BpublicationCriticalpatent/IT1237482B/en
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Alkanoid derived from L-Norcarnitina with the general formula (I)<IMAGE>in which R is a linear or branched, radical alkyl with 1 to 5 carbon atoms, prepared through the reaction of a L-Norcarnitina solution in acetic acid or triflourine acetic acid with a chloride alkanoid thus respectively achieving chloride or acetic triflourine from L-norcarnitina alkanoid. An aqueous solution of these salts is treated with a basic, strong resin, which makes the compounds in the general formula (I). The pharmaceutical composition includes the compounds from the general formula (I) or the acceptable pharmaceutical salts are equipped with activity on the nervous system and hepatic function.
IT04869289A1989-12-221989-12-22Alkanoid derived from L-Norcarnitina, preparation process and pharmaceutical composition.
IT1237482B
(en)
Procedure for the preparation of the acid 7- (d - &- amino- (4hydroxypenyl) -acetamido-3-methyl-3-cefem-4-carboxylic. (Machine-translation by Google Translate, not legally binding)
Legal Events
Date
Code
Title
Description
0001
Granted
TA
Fee payment date (situation as of event date), data collected since 19931001